Anti-TNF-induced lupus — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Anti-TNF-induced lupus
The best answer is “Anti-TNF-induced lupus”. New lupus-like features after anti-TNF treatment, with ANA and anti-dsDNA positivity, indicate anti-TNF-induced lupus. Idiopathic SLE is possible but the temporal relationship to adalimumab and absence of renal disease make drug-induced disease more likely. The key management step is usually withdrawal of the offending biologic and reassessment of the RA strategy. The competing options represent related diagnoses, tests or treatments, but they do not match the decisive phenotype, safety constraint or management point in this stem.
Reference: BSR biologic DMARD safety guideline: https://academic.oup.com/rheumatology/article/58/2/e3/5076446